Concepedia

Melvin Lathara

ML

8

Publications

143

Citations

8

H-Index

2017

Active since

Affiliations

Children's Cancer Therapy Development Institute(Current)

Automatic Data Processing (United States)

Seattle Children's Hospital

Oregon Health & Science University

Institute of Cancer Research

Melvin Lathara is an author at Children's Cancer Therapy Development Institute specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

2017–2022

8

Publications

8

Volasertib preclinical activity in high-risk hepatoblastoma

Dina Kats, Cora A. Ricker, Noah Berlow et al. · Oncotarget · 2019 · 30 citations · Full text

Machine learning for rhabdomyosarcoma histopathology

Arthur O. Frankel, Melvin Lathara, Celine Y. Shaw et al. · Modern Pathology · 2022 · 27 citations

, , +4

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma

Narendra Bharathy, Matthew N. Svalina, Teagan P. Settelmeyer et al. · Oncotarget · 2017 · 19 citations · Full text

Defining the Extracellular Matrix of Rhabdomyosarcoma

Xiaolei Lian, J. Steffan Bond, Narendra Bharathy et al. · Frontiers in Oncology · 2021 · 17 citations · Full text

In vitro benchmarking of NF-κB inhibitors

Alexandria P. Harrold, Megan M. Cleary, Narendra Bharathy et al. · European Journal of Pharmacology · 2020 · 14 citations · Full text

, , +5

Rows per page

1–5 of 8